Biomerica (BMRA) Share-based Compensation Growth (3y) (2014 - 2026)
Biomerica (BMRA) Share-based Compensation Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.40% |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -46.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -46.74% |
| Nov 30, 2025 | -39.05% |
| Aug 31, 2025 | -24.09% |
| May 31, 2025 | -23.05% |
| Feb 28, 2025 | -28.29% |
| Nov 30, 2024 | 85.64% |
| Aug 31, 2024 | -37.78% |
| May 31, 2024 | -15.01% |
| Feb 29, 2024 | -13.33% |
| Nov 30, 2023 | -21.62% |
| Aug 31, 2023 | -11.68% |
| May 31, 2023 | -19.70% |
| Feb 28, 2023 | 34.47% |
| Nov 30, 2022 | 121.84% |
| Aug 31, 2022 | 273.17% |
| May 31, 2022 | 299.64% |
| Feb 28, 2022 | 33.29% |
| Nov 30, 2021 | 185.42% |
| Aug 31, 2021 | 240.67% |
| May 31, 2021 | 253.13% |